Can a PET scan spot silent heart danger from cancer drugs?

NCT ID NCT06566209

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This pilot study tested whether a special PET scan (FDG-PET/CT) can detect hidden heart inflammation in cancer patients receiving immune checkpoint inhibitors (ICIs). The goal was to catch this inflammation early, before it becomes severe. Only 2 participants were enrolled, and the study was terminated early, so the findings are very limited.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Fluorodeoxyglucose (FDG) for PET/CT scan
What this could lead to
If successful, this imaging method could help doctors detect early, hidden heart inflammation in cancer patients on immunotherapy, potentially preventing severe heart problems.
What could go wrong
This was a very small pilot study with only 2 participants and was terminated early, so results are limited. The special diet required for the scan may be hard for some patients to follow.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.